Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

EGX:CPCI Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	504.49	443.72	246.11	97.09	165.74	124.3
Depreciation & Amortization	55.19	36.03	5.32	15.94	-	-
Other Amortization	0.03	0.01	0.01	0.01	-	-
Other Operating Activities	-346.9	-101.04	11.45	-24.52	-113.92	37.95
Operating Cash Flow	212.81	378.72	262.89	88.53	51.83	162.25
Operating Cash Flow Growth	-50.65%	44.06%	196.96%	70.82%	-68.06%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Capital Expenditures	-59.12	-139.47	-216.24	-79.07	-17.31	-23.68
Sale of Property, Plant & Equipment	-	-	-	0.08	0	0.04
Investment in Securities	-	-	-0.84	-	15.86	-14.11
Other Investing Activities	18.59	21.12	-14.5	2.85	4.94	2.62
Investing Cash Flow	-40.52	-118.35	-231.58	-76.14	3.49	-35.13

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Long-Term Debt Issued	-	-	133.88	144.31	-	-
Long-Term Debt Repaid	-	-36.67	-50.76	-28.36	-	-
Net Debt Issued (Repaid)	-40	-36.67	83.12	115.95	-	-
Common Dividends Paid	-212.23	-220.78	-85.53	-100.82	-75.2	-77.73
Financing Cash Flow	-252.23	-257.45	-2.41	15.13	-75.2	-77.73

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Cash Flow	-79.94	2.93	28.9	27.51	-19.89	49.39

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Free Cash Flow	153.7	239.25	46.65	9.45	34.52	138.57
Free Cash Flow Growth	-41.44%	412.87%	393.48%	-72.61%	-75.09%	-
Free Cash Flow Margin	6.42%	11.51%	3.43%	0.94%	3.10%	13.05%
Free Cash Flow Per Share	10.29	16.02	3.12	0.63	2.31	9.28
Levered Free Cash Flow	157.81	146.4	-42.26	57.94	-20.17	97.35
Unlevered Free Cash Flow	167.89	154.86	-30.42	60.12	-20.17	97.35

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash Interest Paid	-	-	-	5.85	-	-
Cash Income Tax Paid	179.29	93	45.89	73.12	51.33	36.22

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error